|
|
|
Volumn , Issue 117, 2001, Pages 8-12
|
|
Diabetes and the hope study: Implications for macrovascular and microvascular disease
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
PLACEBO;
RAMIPRIL;
BLOOD PRESSURE REGULATION;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES MELLITUS;
DIABETIC NEPHROPATHY;
FOLLOW UP;
HIGH RISK PATIENT;
HUMAN;
MAJOR CLINICAL STUDY;
MICROVASCULATURE;
MORTALITY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
STROKE;
AGED;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CEREBROVASCULAR ACCIDENT;
DIABETIC ANGIOPATHIES;
DIABETIC NEPHROPATHIES;
FEMALE;
HUMANS;
MALE;
MYOCARDIAL INFARCTION;
RAMIPRIL;
TREATMENT OUTCOME;
|
|
EID: 33745068502
PISSN: 1368504X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (29)
|
|
References (0)
|
